Efficacy and Safety of Remifentanil as an Alternative Labor Analgesic
Author(s) -
Sandeep Devabhakthuni
Publication year - 2013
Publication title -
clinical medicine insights women s health
Language(s) - English
Resource type - Journals
ISSN - 1179-562X
DOI - 10.4137/cmwh.s8015
Subject(s) - remifentanil , medicine , fentanyl , adverse effect , anesthesia , analgesic , dosing , randomized controlled trial , intensive care medicine , surgery , propofol , pharmacology
The objective of this review was to evaluate the clinical efficacy and safety of remifentanil in the management of labor pain. Although neuraxial analgesia is the best option during labor, alternative analgesic options are needed for patients with contraindications. Using a systematic literature search, clinical outcomes of remifentanil for labor pain have been summarized. Also, comparisons of remifentanil to other options including meperidine, epidural analgesia, fentanyl, and nitrous oxide are provided. Based on the literature review, remifentanil is associated with high overall maternal satisfaction and favorable side-effect profile. However, due to the low reporting of adverse events, large, randomized controlled trials are needed to evaluate maternal and neonatal safety adequately and determine the optimal dosing needed to provide effective analgesia. While remifentanil is a feasible alternative for patients who cannot or do not want to receive epidural analgesia, administration should be monitored closely for potential adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom